A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
Completed · Phase 3
Conditions studied: Migraine
In brief
This is an open-label, twelve-month safety study. There is a screening period followed by a run-in period to record migraine activity. Qualified subjects will receive study medication for up to twelve months for the treatment of multiple migraine attacks. Using the electronic diary (eDiary) to confirm they are experiencing a qualified migraine, subjects will self-administer the patches and respond to questions in the eDiary post treatment administration.
Key facts
- Study ID
- NCT03282227
- Run by
- Zosano Pharma Corporation
- People needed
- 342
- Starts
- 2017-11-07
- Expected to finish
- 2019-05-17
- Last updated by the study team
- 2020-08-19
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Achieve Clinical Research — Birmingham, Alabama, United States
- Elite Clinical Studies — Phoenix, Arizona, United States
- Downtown L.A. Research Center — Los Angeles, California, United States
- Stanford University Medical Center — Palo Alto, California, United States
- Allergy Asthma Associates of Santa Clara Valley Research Center — San Jose, California, United States
- California Medical Clinic for Headache — Santa Monica, California, United States
- Empire Clinical Research — Upland, California, United States
- Colorado Allergy Asthma Centers — Denver, Colorado, United States
- Harmony Medical Research Institute — Hialeah, Florida, United States
- Advanced Clinical Research — Meridian, Idaho, United States
- DelRicht Research — New Orleans, Louisiana, United States
- Boston Clinical Trials — Boston, Massachusetts, United States
- MedVadis Research Corporation — Watertown, Massachusetts, United States
- Michigan Headache and Neurological Institute — Ann Arbor, Michigan, United States
- Clinical Research Institute — Minneapolis, Minnesota, United States
- Clinical Research Institute — Plymouth, Minnesota, United States
- StudyMetrix Research LLC — City of Saint Peters, Missouri, United States
- Clinvest Research — Springfield, Missouri, United States
- Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States
- Albuquerque Clinical Trials — Albuquerque, New Mexico, United States
- Rochester Clinical Research — Rochester, New York, United States
- Peters Medical Research — High Point, North Carolina, United States
- North Carolina Clinical Research — Raleigh, North Carolina, United States
- Raleigh Medical Group PMG Research — Raleigh, North Carolina, United States
- Lillestol Research — Fargo, North Dakota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.